Hr

Webinar: New pathways for treatment of systemic lupus erythematosus

23.06.2021 - 23.06.2021


EULAR Webinar

 

We are delighted to invite you to a virtual meeting: New pathways for treatment of systemic lupus erythematosus (SLE). We hope that you will be able to join us for this engaging webinar in which a panel of global experts will deliver a series of interactive presentations exploring new data presented at EULAR 2021 and how the treatment pathway of SLE is changing. We are pleased to have Prof. Hanns-Martin Lorenz as Chair of this event and he will be joined by Prof. Murray Urowitz, Prof. George Bertsias and Prof. David Isenberg. The event promises to be highly interactive, with opportunity to participate in panel discussions and explore new developments in our disease understanding.

Agenda highlights:
  • Review of the latest evidence in SLE
  • Understanding SLE pathophysiology and potential treatment targets
  • Redefining the treatment pathway in SLE, exploring the current unmet need, and future directions for new treatments
  • From clinical trials to clinical practice in SLE:
    Translating evidence into daily practice

We would be grateful if you could kindly register your interest in attending this meeting by Wednesday, 16th June 2021 via the following link: https://webstreamlive.com/astrazeneca/eucan/230621/

Best wishes,
On behalf of AstraZeneca

 

An Matthys
Medical Director, Respiratory and
Immunology, Europe and Canada

Beate Villinger
Senior Medical Affairs Manager, Immunology